New Delhi: The expert panel of Drug Controller General of India (DCGI) on Thursday recommended that emergency use authorization be granted to the COVID-19 vaccine Corbevax for children in the age group of 5 to 12 years.
Corbevax, developed by Hyderabad-based firm Biological-E, is India’s first indigenously-developed RBD protein sub-unit vaccine against the coronavirus.
It is being administered to children in the age group of 12 to 14 from March 16, 2022.
Meanwhile, the government panel has sought more data from Bharat Biotech before granting emergency use approval to Covaxin among children aged 5-12.
The 5-12 age group is yet to brought under the nationwide inoculation drive.
Hyderabad: At least four people died and several others were injured following a stampede in…
Mumbai: Bollywood actor Salman Khan is the most eligible bachelor, even at the age of…
Bhubaneswar: As the 18th Pravasi Bharatiya Divas celebrations kicked off in Bhubaneswar, the temple city…
Mumbai: Pritish Nandy, a multi-faceted and extremely talented personality, passed away on Wednesday at the…
Mumbai: From tidbits about their married life to her husband's acting career, Govinda's wife Sunita…
Bhubaneswar: The Odisha government will run premium buses from different places in the state to…
This website uses cookies.
